Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Nov 26;17:9773–9793. doi: 10.2147/JIR.S483977

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 Chen et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Integrated assessment of the immune cell landscape of risk models. (A) Association between risk score and immune cell type. (B) Immune cell infiltration between different risk model groups. (C) Immuno-score, Stromal-score, and ESTIMATE-score between different risk models. *p < 0.05; **p < 0.01; ***p < 0.001; ****p<0.0001. (D) In the IMvigor210 cohort, there were variations in risk scores across different clinical responses to anti-PD-L1 treatment. (E) Differences in risk scores for various immunophenotypes in the IMvigor210 cohort.